Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis.
Emerging stem cell therapies: treatment, safety, and biology.
The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients.
Sexual problems among women with multiple sclerosis.
AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?
Stage-Specific Regulation of Oligodendrocyte Development by Wnt/β-Catenin Signaling.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Efficacy of Fish Oil on Serum of TNF α , IL-1 β , and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b.
Transitions between SNF and home-based care in patients with multiple sclerosis.
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1.
Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
Role of puberty in multiple sclerosis risk and course.
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices.
JCV epidemiology in MS (JEMS)-Epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients-Portuguese data.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro.
Vitamin d and long-term memory in multiple sclerosis.
The extracellular domain of myelin oligodendrocyte glycoprotein elicits atypical experimental autoimmune encephalomyelitis in rat and macaque species.
Correction: A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
464
465
466
467
468
469
470
471
472
…
next ›
last »